SEATTLE, WA -- (Marketwired) -- 08/28/14 -- Visualant, Inc. (OTCQB: VSUL), a leading provider of disruptive light-based technologies, has been invited to present at the 2014 Gateway Conference being held on Thursday, September 4, 2014 at the Palace Hotel in San Francisco.
Visualant's Vice President of Business Development, Todd Sames, is scheduled to present at 1:00 p.m. Pacific time, with one-on-one meetings held throughout the day. Management will discuss the company's progress, including the recent patents filed by strategic partner Intellectual Ventures that were based upon Visualant's ChromaID technology.
For additional information or to schedule a one-on-one meeting log-in via the link provided in your invitation. You may also email your request to firstname.lastname@example.org or call Matt Glover or Michael Koehler at (949) 574-3860.
About the Gateway Conference
The Gateway Conference is designed to provide a unique gateway between influential members of the investment community and a select group of compelling publicly-traded companies. Portfolio managers, research analysts and brokers from buy-side and sell-side institutions will have the opportunity to learn about more than 60 small-cap growth companies from a number of growth industries, including technology, business services, digital media, clean-tech, consumer, Internet retail and life sciences. For more information, visit www.gateway-conference.com.
The invitation-only conference is hosted by Liolios Group, one of the nation's top investor relations agencies, and sponsored by leading firms that service the financial community. For more information about Liolios Group, visit www.liolios.com.
About Visualant, Inc.
Visualant is a public company whose shares trade under the stock symbol "VSUL." The Visualant Spectral Pattern Matching (SPM) technology directs structured light onto a substance or material, through a liquid or gas, or off a surface, to capture a unique ChromaID. A ChromaID can be used to identify, detect, or diagnosis markers invisible to the human eye. ChromaID scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented, award-winning technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab-based tests. For more information on Visualant, visit the company's new website at www.visualant.net.